EPO Patents = 4

Forward Citations = 41

Loading Chart...

11 inventors (with patents filed for the assignee):

Fabienne Vernejoul (5 out of 9 patents)

Thierry Lioux (5 out of 8 patents)

Gerard Tiraby (4 out of 11 patents)

4. Daniel Drocourt (4 out of 11 patents)

5. Eric Perouzel (3 out of 3 patents)

6. Arnaud Debin (2 out of 2 patents)

7. Antoine Blancher (1 out of 2 patents)

8. Nicolas Congy (1 out of 2 patents)

9. Jean-Gerard Tiraby (1 out of 2 patents)

10. Cédric Boularan (1 out of 1 patent)

11. Michèle Tiraby (1 out of 2 patents)

12. Gérard Tiraby (2 patents)

13. Céline Casteran (1 patent)

14. Jean-Paul Reynes (1 patent)

6 patents: Sort by Forward Citations

1. 11730817 - Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction (2023-08-22),

2. 10011630 - Cyclic dinucleotides for cytokine induction (2018-07-03),

3. 9637538 - Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin (2017-05-02),

4. 9567336 - Conjugated TLR7 and/or TLR8 and TLR2 agonists (2017-02-14),

5. 9458184 - Compositions of TLR7 and/or TLR8 agonists conjugated to lipids (2016-10-04),

6. 9295732 - Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists (2016-03-29),

Invivogen is a biotechnology company that specializes in developing and manufacturing innovative tools for the life science research community. With a focus on immunology, Invivogen offers a wide range of products including reagents, kits, and cell lines for studying innate and adaptive immune responses. By providing high-quality tools and cutting-edge technologies, Invivogen is dedicated to advancing research in the fields of immunology and infectious diseases.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#21 in Toulouse

#2,485 in France

Toulouse, France

Invivogen